Philippe Weigerstorfer

CIK: 0001751449

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SNOA

Sonoma Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

SNOA
Sonoma Pharmaceuticals, Inc.
Jul 9, 2026
Award(A)
Stock option (right to buy)
Direct
10K shares-
SNOA
Sonoma Pharmaceuticals, Inc.
Jan 2, 2026
Award(A)
Stock option (right to buy)
Direct
10K shares-
SNOA
Sonoma Pharmaceuticals, Inc.
Jan 2, 2025
Award(A)
Stock option (right to buy)
Direct
7.5K shares-

		Type	Shares	Price		Ownership
Jul 9, 2026	SNOA Sonoma Pharmaceuticals, Inc.	Award(A) Stock option (right to buy)	10,000	-	-	Direct
Jan 2, 2026	SNOA Sonoma Pharmaceuticals, Inc.	Award(A) Stock option (right to buy)	10,000	-	-	Direct
Jan 2, 2025	SNOA Sonoma Pharmaceuticals, Inc.	Award(A) Stock option (right to buy)	7,500	-	-	Direct

1-3 of 3 transactions

About Weigerstorfer Philippe

Weigerstorfer Philippe (SEC CIK 0001751449) files insider reports with the SEC as Director of Sonoma Pharmaceuticals, Inc. (SNOA).

Signal8 holds 3 ownership filings by Weigerstorfer Philippe, all Form 4s, filed between Jan 3, 2025 and Jul 9, 2026. Those filings report 3 transactions, from Jan 2, 2025 to Jul 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Weigerstorfer Philippe's filings is in BOULDER, CO.

Recent filings by Weigerstorfer Philippe

Jul 9, 2026: Grant or award of SNOA derivative securities (Form 4, code A).
Jan 2, 2026: Grant or award of SNOA derivative securities (Form 4, code A).
Jan 2, 2025: Grant or award of SNOA derivative securities (Form 4, code A).

Other insiders filing for Sonoma Pharmaceuticals, Inc. (SNOA)

Trombly Amy Moss, Chief Executive Officer
MCLAUGHLIN JOHN, Director
Jacoby Vanessa, Director
DVONCH JEROME J, Chief Financial Officer
Dal Poggetto John, Controller
Birnbaum Jay E, Director

How to read Form 4 transaction codes